Onabotulinumtoxin Type A Reconstitution With Preserved Versus Preservative-free Saline in Chronic Migraine. (B-RECON)
Onabotulinumtoxin Type A Reconstitution With Preserved Versus Preservative-free Saline in Chronic Migraine. A Randomized, Double-blind Trial.
Sponsor: State University of New York - Upstate Medical University
This PHASE4 trial investigates Chronic Migraine, Headache and is currently completed. State University of New York - Upstate Medical University leads this study, which shows 9 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jul 2022 — Jul 2024 [monthly]
Completed PHASE4
Status: Not Yet Recruiting → Completed
-
Mar 2022 — Jul 2022 [monthly]
Not Yet Recruiting PHASE4
Status: Unknown Status → Not Yet Recruiting
-
Dec 2021 — Mar 2022 [monthly]
Unknown Status PHASE4
Status: Not Yet Recruiting → Unknown Status
▶ Show 4 earlier versions
-
Nov 2021 — Dec 2021 [monthly]
Not Yet Recruiting PHASE4
Status: Unknown Status → Not Yet Recruiting
-
Jan 2021 — Nov 2021 [monthly]
Unknown Status PHASE4
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Not Yet Recruiting → Unknown Status
-
Nov 2018 — Nov 2020 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- State University of New York - Upstate Medical University
For direct contact, visit the study record on ClinicalTrials.gov .